Urge your legislators to support HB 1062 to increase coverage for biomarker testing!

Biomarker testing is the analysis of a patient's tissue, blood, or other biospecimen for the presence of a biomarker. Biomarker testing is a crucial step for accessing precision medicine, including targeted therapies that can lead to improved survivorship and better quality of life for chronic disease patients.

 

Given the complexity of arthritic diseases and demographics impacted, understanding arthritis is the first step in managing it. Symptoms of types of arthritis can vary and even be mistaken for other illnesses and disorders, so biomarker testing is imperative to pinpointing the diagnosis, prognosis and treatment plan. Considering there are multiple classes of drugs to treat types of arthritis, using biomarking testing can aid in administering precise care. Revolutionizing health outcomes through more targeted therapies can lead to improved survivorship and better mobility and quality of life for patients.

    Subject
    Message Body
    Post
    Suggested Message
    Post
    Remaining: 0
  • Hide
    • Please call this number:

      Please do not close this window. You will need to come back to this window to enter your code.
      We just sent an email to ... containing a verification code.

      If you do not see the email within the next five minutes, please ensure you entered the correct email address and check your spam/junk mail folder.
      Enter Your Info
      Your Information
      By providing your mobile number, you agree to receive periodic call to action text messages from Arthritis Foundation. Message and data rates may apply. Reply HELP for help. Reply STOP to unsubscribe. Message frequency varies. Privacy Policy  
      Home Information

      Enter Your Info